BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.69 USD | -13.71% |
|
-12.29% | -76.49% |
| May. 10 | Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates | MT |
| Apr. 25 | Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing | MT |
Presenter SpeechVladimir Coric (Executives)I'm Vlad Coric, the CEO of Biohaven, and wanted to ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Biohaven Pharmaceutical Holding Company Ltd. is a United States-based commercial-stage biopharmaceutical company. The Company has a portfolio of therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. The Company's Neuroinnovation portfolio includes NURTEC ODT (rimegepant) for the acute and preventive treatment of migraine and a pipeline of product candidates across five platforms: calcitonin gene related peptide (CGRP) receptor antagonism for the acute and preventive treatment of migraine as well as other pain-related disorders and non-migraine indications; glutamate modulation for obsessive-compulsive disorder (OCD); myeloperoxidase (MPO) inhibition for multiple system atrophy (MSA) and amyotrophic lateral sclerosis (ALS); Kv7 Ion Channel Activators (Kv7) to target indications including epilepsy, pain disorders and effective disorders; and Myostatin offers a natural protein that limits skeletal muscle growth.
| 1st Jan change | Capi. | |
|---|---|---|
| -76.49% | 541M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Transcript : Biohaven Pharmaceutical Holding Company Ltd. - Special Call
